UNIGE document Scientific Article
previous document  unige:43659  next document
add to browser collection
Title

β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial

Authors
Carballo, Sebastian
Chuard, Christian
Eich, Gerhardt
Hugli, Olivier
Lamy, Olivier
show hidden authors show all authors [1 - 14]
Published in JAMA Internal Medicine. 2014, vol. 174, no. 12, p. 1894-1901
Abstract The clinical benefit of adding a macrolide to a β-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial.
Identifiers
PMID: 25286173
Full text
Article (Published version) (707 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Acquisition de l'expertise médicale (662)
Epidémiologie clinique (115)
Groupe Harbarth Stephan (Staphylocoques dorés résistants à la méthicilline) (866)
Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) (585)
Groupe Petignat Patrick (933)
Citation
(ISO format)
GARIN, Nicolas et al. β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA Internal Medicine, 2014, vol. 174, n° 12, p. 1894-1901. doi: 10.1001/jamainternmed.2014.4887 https://archive-ouverte.unige.ch/unige:43659

456 hits

0 download

Update

Deposited on : 2014-12-17

Export document
Format :
Citation style :